Immuneering Reports Second Quarter 2026 Financial Results and Provides Business Updates
Go back to Immuneering Reports Second Quarter 2026 Financial Results and Provides Business Updates| ImaRx Therapeutics, Inc. (NASDAQ: IMRX) | Delayed: 4.84 -0.01 (0.21%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $4.85 | 52 Week High | $0.04 | |||
| Open | $4.85 | 52 Week Low | $0.00 | |||
| Day High | $5.04 | P/E | N/A | |||
| Day Low | $4.80 | EPS | $-0.09 | |||
| Volume | 187,188 | |||||
